Latest topics | Infection Update

LATEST TOPICS

Respiratory syncytial virus (RSV) – not bacteria – a leading cause of childhood pneumonia

02 August, 2019

Researchers of the Pneumonia Etiology Research for Child Health (PERCH) study reported that viruses are the leading cause of severe pneumonia in children younger than five years without human immunodeficiency...

Researchers of the Pneumonia Etiology Research for Child Health (PERCH) study reported that viruses are the leading cause of severe pneumonia in children younger than five years without human immunodeficiency...

Previously unknown bacterial communities responsible for recurrent urinary tract infections in postmenopausal women

Researchers at The University of Texas (UT) at Dallas and UT Southwestern Medical Center have identified several species of bacteria that form bacterial communities responsible for recurrent urinary tract infections...

Researchers at The University of Texas (UT) at Dallas and UT Southwestern Medical Center have identified several species of bacteria that form bacterial communities responsible for recurrent urinary tract infections...

Superbugs found on patients’ hands at the start of hospitalisation

The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) have been advocating for hand hygiene as an important tool in infection control within healthcare facilities.1,2 Campaigns...

The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) have been advocating for hand hygiene as an important tool in infection control within healthcare facilities.1,2 Campaigns...

Levofloxacin: High-dose, short-course for bacterial infection

Associate Professor Panpit Suwangool Bangkok Hospital, Thailand Levofloxacin is a well-established antibacterial for respiratory and urinary tract infections.1 Levofloxacin is active against some penicillin- and macrolide- resistant pathogens including Streptococcus...

Associate Professor Panpit Suwangool Bangkok Hospital, Thailand Levofloxacin is a well-established antibacterial for respiratory and urinary tract infections.1 Levofloxacin is active against some penicillin- and macrolide- resistant pathogens including Streptococcus...

Oral sitafloxacin vs intravenous ceftriaxone for the treatment of acute pyelonephritis and complicated urinary tract infection

An open-label randomised, controlled, noninferiority clinical trial has shown that oral sitafloxacin is noninferior to intravenous (IV) ceftriaxone followed by oral cefdinir for the treatment of acute pyelonephritis and complicated...

An open-label randomised, controlled, noninferiority clinical trial has shown that oral sitafloxacin is noninferior to intravenous (IV) ceftriaxone followed by oral cefdinir for the treatment of acute pyelonephritis and complicated...

Levofloxacin remains as one of the core agents in the treatment of tuberculosis

According to the current World Health Organization (WHO) guidelines (2016 update), fluoroquinolones including moxifloxacin, gatifloxacin, and levofloxacin are important second-line anti-tuberculosis (anti-TB) agents.1 A review of existing literature conducted by...

According to the current World Health Organization (WHO) guidelines (2016 update), fluoroquinolones including moxifloxacin, gatifloxacin, and levofloxacin are important second-line anti-tuberculosis (anti-TB) agents.1 A review of existing literature conducted by...

First malaria saliva test identifies malaria parasites

Researchers have developed a non-invasive, easy-to-use saliva test to screen for malaria parasites before patients present any clinical symptoms. An estimated 219 million malaria cases were reported in 2017 –...

Researchers have developed a non-invasive, easy-to-use saliva test to screen for malaria parasites before patients present any clinical symptoms. An estimated 219 million malaria cases were reported in 2017 –...

Oral levofloxacin and intravenous vancomycin for bacteraemia due to Microbacterium paraoxydans

A patient with bacteraemia associated with a long-term central venous catheter (CVC) due to Microbacterium paraoxydans responded well to replacement of CVC, and treatment with oral levofloxacin and intravenous vancomycin....

A patient with bacteraemia associated with a long-term central venous catheter (CVC) due to Microbacterium paraoxydans responded well to replacement of CVC, and treatment with oral levofloxacin and intravenous vancomycin....

Levofloxacin for lower lobe pneumonia presenting as persistent hiccups

Levofloxacin has been shown to resolve a case of community-acquired pneumonia in an elderly patient presenting with persistent hiccups – without any typical symptoms, signs, or laboratory findings of pneumonia....

Levofloxacin has been shown to resolve a case of community-acquired pneumonia in an elderly patient presenting with persistent hiccups – without any typical symptoms, signs, or laboratory findings of pneumonia....

2018 Taiwan’s pneumonia guidelines: What’s new?

Dr Susan Shin-Jung Lee, MD, PhD Associate Professor, National Yang Ming University, Taipei, Taiwan. Chief, Division of Infectious Diseases, Department of Internal Medicine; Chief, Division of Microbiology, Department of Pathology...

Dr Susan Shin-Jung Lee, MD, PhD Associate Professor, National Yang Ming University, Taipei, Taiwan. Chief, Division of Infectious Diseases, Department of Internal Medicine; Chief, Division of Microbiology, Department of Pathology...

POPULAR ARTICLES